First Houston Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
First Houston Capital's ABBV Position: Q2 2017 in Review
First Houston Capital increased its AbbVie (ABBV) stake by 15% in Q2 2017, buying an estimated $94.1K and bringing the position to 10,500 shares worth $761K. The position accounts for 0.76% of the portfolio, ranked #44.
First Houston Capital first reported a position in ABBV in Q3 2013 and has held it in 16 quarters since. The position peaked at $1.29M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.
- First Houston Capital held 10,500 shares of AbbVie worth $761K as of Q2 2017.
- First Houston Capital bought 1,400 AbbVie shares in Q2 2017, an estimated $94.1K.
- AbbVie made up 0.76% of First Houston Capital's portfolio in Q2 2017, its #44 holding.
- First Houston Capital first reported a position in AbbVie in Q3 2013 and has held it in 16 quarters since.
- First Houston Capital's AbbVie position peaked at $1.29M in Q3 2016.
- 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.
Based on First Houston Capital's 13F filing for Q2 2017, filed 7 Aug 2017.